Skip to main content
. 2022 Sep 8;18(11):1270–1276. doi: 10.1038/s41589-022-01140-1

Extended Data Fig. 9. The CrossMAb IgG ReconnAb neutralizes better than bivalent ACE2 (Fc-ACE2).

Extended Data Fig. 9

(A) Schematic depicting the protein design for Fc-tagged ACE2. Fc fusion was put C-terminal of the ACE2 ectodomain. (B) Neutralization of Fc-ACE2 against the same VOCs tested as in Fig.6 depicts weaker neutralization compared to the IgG ReconnAb. (C) a table of neutralizing potency of the IgG ReconnAb compared to Fc-ACE2 and the fold improvement for the IgG ReconnAb compared to Fc-ACE2.